Chest Trauma Scoring Systems as Predictors of Morbidity and Mortality in Iraq
ConditionChest Injury Trauma Blunt
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAl-Nahrain University
About this trial
This prospective observational study aims to evaluate the effectiveness of chest trauma scoring systems in predicting morbidity and mortality in patients with blunt chest trauma in Iraq. The primary questions it seeks to address are:
How accurately do chest trauma scoring systems predict mortality and critical outcomes such as ICU admission or the need for advanced interventions? How well do these scoring systems stratify patients based on injury severity in a resource-limited setting? Are there any demographic or clinical factors that impact the predictive performance of these scoring systems?
Participants will:
Be assessed using chest trauma scoring systems upon arrival at the emergency department to determine risk levels.
Have demographic and clinical data, including age, gender, injury mechanism, comorbidities, and length of hospital stay, collected to explore potential associations with outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients diagnosed with blunt chest trauma.
Patients presenting to the emergency department within 4 hours.
Patients (or their legal representatives) must provide informed consent to participate in the study.
Patients who can be assessed using the Chest Trauma Score at the time of arrival (e.g., having stable enough vitals to allow for evaluation).
Disqualifiers
Patients with penetrating chest trauma (e.g., gunshot or stab wounds), as the Chest Trauma Score is typically used for blunt trauma.
Patients presenting with chest conditions unrelated to trauma (e.g., pneumonia, COPD exacerbation, or other non-traumatic causes of chest pain or respiratory distress).
Patients with severe pre-existing comorbidities (e.g., end-stage heart failure, terminal cancer) where trauma is unlikely to be the primary cause of morbidity or mortality.
Patients with missing or incomplete clinical data, including imaging or vital signs necessary to calculate the CTS accurately.
Trial population
The study population will consist of adult patients aged 18 years and older presenting to the emergency department with blunt chest trauma. Participants will be assessed using the Chest Trauma Score (CTS) to predict morbidity and mortality, and data on demographics, injury mechanisms, and clinical outcomes will be collected. The study aims to include a diverse sample from varying age groups and both genders to evaluate the score's performance across different subgroups.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
In hospital mortality
Mortality (death) during hospitalization.
Time frame
In-Hospital Phase (average of 10 days through discharge); Post-Discharge Follow-Up: Day 7, Day 302
Accuracy Assessment of the Chest Trauma Score (CTS)
The total score ranges from 2 to 12, with higher scores indicating worse outcomes.
Time frame
the first 4 hours after ER admissionSecondary outcomes
1
Number of Participants Requiring ICU Admission
The requirement for admission to the intensive care unit (ICU) is determined by the presence of severe clinical deterioration, significant complications, or the need for advanced monitoring and life-support measures.
Time frame
Up to discharge, an average of 10 daysSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: